Jeffrey Scott Cole - Feb 7, 2024 Form 3 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Chief Operating Officer
Signature
/s/ Matthew K. Szot, Attorney-in-fact
Stock symbol
CVKD
Transactions as of
Feb 7, 2024
Transactions value $
$0
Form type
3
Date filed
4/3/2024, 05:19 PM
Next filing
Apr 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVKD Stock Options Feb 7, 2024 Common Stock 50K $0.64 Direct F1
holding CVKD Stock Options Feb 7, 2024 Common Stock 150K $0.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of options to purchase 50,000 shares of common stock granted on July 11, 2022, which vested fully on August 1, 2023.
F2 Consists of options to purchase 150,000 shares of common stock granted on January 18, 2024, which vest 1/4 on February 1, 2025 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

Exhibit List - Exhibit 24- Power of Attorney (Jeffrey S. Cole)